Witte T, Hartung K, Matthias T, Sachse C, Fricke M, Deicher H, Kalden J R, Lakomek H J, Peter H H, Schmidt R E
Abteilung Klinische Immunologie, Medizinische Hochschule, Hannover, Germany.
Rheumatol Int. 1998;18(2):63-9. doi: 10.1007/s002960050059.
Previously it has been suggested that the presence of antibodies against dsDNA of the IgA class may define a subset of systemic lupus erythematosus (SLE) patients suffering from nephritis and arthritis. Therefore, these autoantibodies were measured in sera of 352 patients with SLE, 81 blood donors, and 189 patients with rheumatoid arthritis using a new ELISA based on human recombinant dsDNA as antigen. IgA anti-dsDNA antibodies were found in 19.9% of the sera from patients with SLE, but in none of the sera from 81 normal controls and 189 patients with rheumatoid arthritis. The association of these autoantibodies with 31 clinical and 36 laboratory parameters was calculated. IgA anti-dsDNA antibodies were found to be associated with parameters of disease activity such as elevated erythrocyte sedimentation rate and consumption of complement component C3, and the clinical parameters vasculitis, with necrosis and erythema, but not with nephritis and arthritis. Therefore, IgA anti-dsDNA antibodies define a subset of SLE patients, and monitoring of IgA anti-dsDNA antibodies may be helpful as a prognostic parameter in patients with SLE.
此前有人提出,IgA类抗双链DNA抗体的存在可能界定了患有肾炎和关节炎的系统性红斑狼疮(SLE)患者的一个亚组。因此,使用基于重组人双链DNA作为抗原的新型酶联免疫吸附测定法(ELISA),对352例SLE患者、81名献血者和189例类风湿性关节炎患者的血清进行了这些自身抗体的检测。在19.9%的SLE患者血清中发现了IgA抗双链DNA抗体,但在81名正常对照者和189例类风湿性关节炎患者的血清中均未发现。计算了这些自身抗体与31项临床参数和36项实验室参数之间的关联。发现IgA抗双链DNA抗体与疾病活动参数相关,如红细胞沉降率升高和补体成分C3消耗,以及临床参数血管炎伴坏死和红斑,但与肾炎和关节炎无关。因此,IgA抗双链DNA抗体界定了SLE患者的一个亚组,监测IgA抗双链DNA抗体可能有助于作为SLE患者的一个预后参数。